# Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI

> **NCT03406832** · NA · UNKNOWN · sponsor: **The First Affiliated Hospital of Zhengzhou University** · enrollment: 1000 (estimated)

## Conditions studied

- ST Segment Elevation Myocardial Infarction
- Elective Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Nitroprusside Sodium
- **DRUG:** Tirofiban Hydrochloride
- **DRUG:** Heparinized saline

## Key facts

- **NCT ID:** NCT03406832
- **Lead sponsor:** The First Affiliated Hospital of Zhengzhou University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-08
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2019-06-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03406832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03406832, "Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03406832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*